<!DOCTYPE html>
<html class="no-js" lang="en-gb" dir="ltr">
  <head>
    <meta charset="utf-8">
    <meta name="viewport" content="width=device-width, initial-scale=1">
<title>Novogen | Latest Presentations</title>
<link rel="apple-touch-icon" sizes="57x57" href="img/favicons/apple-touch-icon-114x114.png">
<link rel="apple-touch-icon" sizes="114x114" href="img/favicons/apple-touch-icon-114x114.png">
<link rel="apple-touch-icon" sizes="72x72" href="img/favicons/apple-touch-icon-72x72.png">
<link rel="apple-touch-icon" sizes="144x144" href="img/favicons/apple-touch-icon-144x144.png">
<link rel="apple-touch-icon" sizes="60x60" href="img/favicons/apple-touch-icon-60x60.png">
<link rel="apple-touch-icon" sizes="120x120" href="img/favicons/apple-touch-icon-120x120.png">
<link rel="apple-touch-icon" sizes="76x76" href="img/favicons/apple-touch-icon-76x76.png">
<link rel="apple-touch-icon" sizes="152x152" href="img/favicons/apple-touch-icon-152x152.png">
<link rel="apple-touch-icon" sizes="180x180" href="img/favicons/apple-touch-icon-180x180.png">
<link rel="icon" type="image/png" href="img/favicons/favicon-192x192.png" sizes="192x192">
<link rel="icon" type="image/png" href="img/favicons/favicon-160x160.png" sizes="160x160">
<link rel="icon" type="image/png" href="img/favicons/favicon-96x96.png" sizes="96x96">
<link rel="icon" type="image/png" href="img/favicons/favicon-16x16.png" sizes="16x16">
<link rel="icon" type="image/png" href="img/favicons/favicon-32x32.png" sizes="32x32">
<meta name="msapplication-TileColor" content="#21c4c2">
<meta name="msapplication-TileImage" content="img/favicons/mstile-144x144.png">
<meta name="description" content="Bio-pharmaceutical company using breakthrough technology to create the CS-6 family of drugs to selectively kill cancer stem cells, without side effects.">
<meta name="keywords" content="Novogen owns two proprietary drug technology platforms that are first-in-class Both technologies target essential functions that lie at the heart of cells behaving abnormally. These essential functions are present across a wide range of degenerative diseases including cancer, neurodegenerative disorders and autoimmune diseases. Novogen believes exploiting them will revolutionize the treatment of many of the common diseases affecting our community and for which no curative treatments currently exist. The first of our technologies is a family of small molecules known as super- benzopyrans (SBPs). SBPs regulate the function of tissue stem cells. The second technology is our anti-tropomyosin (ATM) technology, targeting the micro-filament component of a cancer cell&#39;s cytoskeleton" />
<link href="http://fonts.googleapis.com/css?family=Raleway:400,300,500" rel="stylesheet" type="text/css">
<link rel="stylesheet" href="bower_components/uikit/fonts/FontAwesome.otf">
<link rel="stylesheet" href="bower_components/uikit/css/mystyle.css">
<script src="bower_components/jquery/dist/modernizr.custom.89200.js"></script>
<!--[if lt IE 9]>
<script src="bower_components/jquery/dist/html5shiv.min.js"></script>
<script src="bower_components/jquery/dist/respond.min.js"></script>
<script>  if (!Modernizr.svg) {
  $('img[src$=".svg"]').each(function() {
      $(this).attr('src', $(this).attr('src').replace('.svg', '.png'));
  });
}
</script>
<![endif]-->
<script src="bower_components/jquery/dist/jquery.min.js"></script>
<script src="bower_components/uikit/js/uikit.min.js"></script>
<script src="bower_components/uikit/js/core/offcanvas.min.js"></script>
<script src="bower_components/uikit/js/components/slideshow.min.js"></script>
<script src="bower_components/uikit/js/components/slideshow-fx.min.js"></script>
<script src="bower_components/uikit/js/components/cover.min.js"></script>
<script src="bower_components/uikit/js/components/sticky.min.js"></script>
<script src="bower_components/jquery/dist/swapimages.js"></script>
<script>
  (function(i, s, o, g, r, a, m) {
    i['GoogleAnalyticsObject'] = r;
    i[r] = i[r] || function() {
      (i[r].q = i[r].q || []).push(arguments)
    }, i[r].l = 1 * new Date();
    a = s.createElement(o),
      m = s.getElementsByTagName(o)[0];
    a.async = 1;
    a.src = g;
    m.parentNode.insertBefore(a, m)
  })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
  ga('create', 'UA-55268236-1', 'auto');
  ga('send', 'pageview');
</script>
</head>
<body>
  <div class="social-bar uk-vertical-align">
    <div class="share-icons uk-vertical-align-middle uk-grid uk-width-1-1"> <span class="share-wrap uk-width-1-2">
      <a href="http://www.nasdaq.com/symbol/nvgn" target="_blank"><img src="img/nasdaq.svg" class="nasdaq-top" alt="Nasdaq stock price for Novogen"></a>
      <a href="http://www.asx.com.au/asx/research/companyInfo.do?by=asxCode&asxCode=NRT" target="_blank"><img src="img/ASX.svg" class="asx-top" alt="Australian Stock Exchange stock price for Novogen"></a>
      </span>
      <span class="social-wrap uk-width-1-2">
        <a href="https://twitter.com/Novogen" target="_blank"><img src="img/twitter.png" class="twitter-top uk-float-right" alt="Novogen twitter"></a>
        <a href="https://www.linkedin.com/company/novogen" target="_blank"><img src="img/LinkedIn.svg" class="linkedin-top uk-float-right" alt="Novogen LinkedIn"></a>
        <a href="https://www.youtube.com/channel/UCzNMflCMfqL-kTzanKU-gDQ" target="_blank"><img src="img/youtube.svg" class="utube-top uk-float-right" alt="Novogen Youtube"></a>
      </span>

    </div>
  </div>
  <nav class="uk-navbar uk-navbar-attached" data-uk-sticky>
    <a class="logo" href="index.html">
      <img src="img/novogen-logo.svg" alt="Novogen web site">
    </a>
    <ul class="uk-navbar-nav uk-navbar-flip uk-hidden-small">
      <li class="menu-item">
        <a href="index.html">Home</a>
      </li>
      <li class="menu-item" data-uk-dropdown>
        <a href="about.html">About</a>
        <div class="long-list uk-dropdown uk-dropdown-navbar">
          <ul class="uk-nav uk-nav-navbar">
            <li>
              <a href="history.html">Our Story</a>
            </li>
            <li>
              <a href="vision.html">Vision</a>
            </li>
            <li>
              <a href="vision.html#ethos">Ethos</a>
            </li>
            <li>
              <a href="theboard.html">Board</a>
            </li>
            <li>
              <a href="management.html">Management</a>
            </li>
          </ul>
        </div>
      </li>
      <li class="menu-item" data-uk-dropdown>
        <a href="programs.html">Programs</a>
        <div class="longer-list uk-dropdown uk-dropdown-navbar">
          <ul class="uk-nav uk-nav-navbar">
            <li>
              <a href="programs.html">PIPELINE</a>
            </li>
            <li>
              <a href="pdf/cantrixil.pdf" target="_blank">CANTRIXIL</a>
            </li>
            <li>
              <a href="pdf/TRXE-0025January2015.pdf" target="_blank">TRXE-0025</a>
            </li>
            <li>
              <a href="#tri-box" target="_blank">TRILEXIUM</a>
            </li>
            <li>
              <a href="pdf/atmJanuary2015.pdf" target="_blank">ANISINA</a>
            </li>
            <li>
              <a href="pdf/jacobHopeJanuary2015.pdf" target="_blank">PROJECT JACOB HOPE</a>
            </li>
          </ul>
        </div>
      </li>
      <li class="menu-item" data-uk-dropdown>
        <a href="investors.html">Investors</a>
        <div class="long-list uk-dropdown uk-dropdown-navbar">
          <ul class="uk-nav uk-nav-navbar">
            <li>
              <a href="latest-presentations.html">LATEST PRESENTATIONS</a>
            </li>
            <li>
              <a href="media.html">MEDIA</a>
            </li>
            <li>
              <a href="news.html">NEWS</a>
            </li>
            <li>
              <a href="meip.html">MEIP IN-SPECIE DISTRIBUTION</a>
            </li>
            <li>
              <a href="corporate-governance.html">CORPORATE GOVERNANCE</a>
            </li>
            <li>
              <a href="shares.html">SHARE PRICE</a>
            </li>
            <!-- <li>
<a href="sec.html">SEC FILINGS</a>
</li> -->
            <li>
              <a href="http://www.nasdaq.com/symbol/nvgn/sec-filings" target="_blank">SEC FILINGS</a>
            </li>
            <li>
              <a href="http://www.asx.com.au/asx/statistics/announcements.do?by=asxCode&asxCode=NRT&timeframe=D&period=M6" target="_blank">ASX ANNOUNCEMENTS</a>
            </li>
            <!-- <li>
<a href="asx.html">ASX ANNOUNCEMENTS</a>
</li> -->
            <li>
              <a href="analyst-reports.html">ANALYST REPORTS</a>
            </li>
            <li>
              <a href="annual-reports.html">ANNUAL REPORTS</a>
            </li>
          </ul>
        </div>
      </li>
      <li class="menu-item">
        <a href="contact.html">Contact</a>
      </li>
    </ul>
    <a href="#mobi-nav" class="uk-navbar-toggle uk-visible-small uk-float-right" data-uk-offcanvas>MENU</a>
  </nav>
  <div id="mobi-nav" class="uk-offcanvas">
    <div class="uk-offcanvas-bar">
      <ul class="uk-nav uk-nav-offcanvas uk-nav-parent-icon" data-uk-nav>
        <li>
          <a href="">MENU</a>
        </li>
        <li class="uk-active">
          <a href="index.html">HOME</a>
        </li>
        <li class="uk-parent">
          <a href="#">ABOUT</a>
          <ul class="uk-nav-sub">
            <li>
              <a href="about.html">ABOUT PAGE</a>
            </li>
            <li>
              <a href="history.html">OUR STORY</a>
            </li>
            <li>
              <a href="vision.html">VISION</a>
            </li>
            <li>
              <a href="vision.html#ethos">ETHOS</a>
            </li>
            <li>
              <a href="theboard.html">BOARD</a>
            </li>
            <li>
              <a href="management.html">MANAGEMENT</a>
            </li>
          </ul>
        </li>
        <li class="uk-parent">
          <a href="#">PROGRAMS</a>
          <ul class="uk-nav-sub">
            <li>
              <a href="programs.html">PIPELINE</a>
            </li>
            <li>
              <a href="pdf/cantrixil.pdf" target="_blank">CANTRIXIL</a>
            </li>
            <li>
              <a href="pdf/TRXE-0025January2015.pdf" target="_blank">TRXE-0025</a>
            </li>
            <li>
              <a href="pdf/trilexiumJanuary2015.pdf" target="_blank">TRILEXIUM</a>
            </li>
            <li>
              <a href="pdf/atmJanuary2015.pdf" target="_blank">ANISINA</a>
            </li>
            <li>
              <a href="pdf/jacobHopeJanuary2015.pdf" target="_blank">PROJECT JACOB HOPE</a>
            </li>
          </ul>
        </li>
        <li class="uk-parent">
          <a href="#">INVESTORS</a>
          <ul class="uk-nav-sub">
            <li><a href="investors.html">INVESTORS PAGE</a></li>
            <li>
              <a href="latest-presentations.html">LATEST PRESENTATIONS</a>
            </li>
            <li>
              <a href="media.html">MEDIA</a>
            </li>
            <li>
              <a href="news.html">NEWS</a>
            </li>
            <li>
              <a href="meip.html">MEIP IN-SPECIE DISTRIBUTION</a>
            </li>
            <li>
              <a href="corporate-governance.html">CORPORATE GOVERNANCE</a>
            </li>
            <li>
              <a href="shares.html">SHARE PRICE</a>
            </li>
            <!-- <li>
<a href="http://www.nasdaq.com/symbol/nvgn" target="_blank">SEC FILINGS</a>
</li> -->
            <li>
              <a href="http://www.nasdaq.com/symbol/nvgn/sec-filings" target="_blank">SEC FILINGS</a>
            </li>
            <li>
              <a href="http://www.asx.com.au/asx/statistics/announcements.do?by=asxCode&asxCode=NRT&timeframe=D&period=M6" target="_blank">ASX FILINGS</a>
            </li>
            <!-- <li>
<a href="asx.html">ASX ANNOUNCEMENTS</a>
</li> -->
            <li>
              <a href="analyst-reports.html">ANALYST REPORTS</a>
            </li>
            <li>
              <a href="annual-reports.html">ANNUAL REPORTS</a>
            </li>
            <li>
              <a href="http://www.asx.com.au/asx/research/companyInfo.do?by=asxCode&asxCode=NRT" target="_blank">ASX</a>
            </li>
            <li>
              <a href="http://www.nasdaq.com/symbol/nvgn" target="_blank">NASDAQ</a>
            </li>
          </ul>
        </li>
        <li class="uk-nav-header">Connect with us</li>
        <li>
          <a href="contact.html"><i class="uk-icon-envelope-o"></i> Contact</a>
        </li>
        <li>
          <a href="https://www.youtube.com/channel/UCzNMflCMfqL-kTzanKU-gDQ" target="_blank"><i class="uk-icon-youtube"></i> YouTube</a>
        </li>
        <li>
          <a href="https://twitter.com/Novogen" target="_blank"><i class="uk-icon-twitter"></i> Twitter</a>
        </li>
        <li>
          <a href="https://www.linkedin.com/company/novogen" target="_blank"><i class="uk-icon-linkedin"></i> LinkedIn</a>
        </li>
      </ul>
    </div>
  </div>
<div class="news-top uk-vertical-align">
  <div class="uk-vertical-align-middle">
    <h1>Latest Presentations</h1>
  </div>
</div>
<div class="annual-text"><h4>
  On this page you will find links to our investor presentations. The video presentations may be viewed directly in the video player windows below. The Powerpoint presentations can be downloaded as pdf's. Some of the files can be large so please be patient while they download.
  </h4>
  <p><em>Important Statement on Copyright</em></p><p>Images and information contained within these presentations remain the property of Novogen and certain collaborators and MAY NOT be used or reproduced without the PERMISSION of Novogen.</p>
</div>
<section class="news">
  <ul class="uk-list uk-list-striped">
    <li>
      <div class="img-date"><img src="img/video-green.svg" alt="News Announcement"><p class="uk-text-muted">5 December 2014</p></div>
      <h1 uk-article-title>Video Update on Cantrixil by Dr Kelly</h1>
    </a>
  <p>
    <a class="read-more uk-button uk-button-primary" data-uk-toggle="{target:'#pres-5december'}"> Read More</a>
  </p>
  <article class="uk-article uk-hidden" id="pres-5december">
    <div class="hidden-text-wrap">
      <p class="uk-article-meta">5 December 2014, Sydney, Australia: Novogen Limited (ASX:NRT;
        NASDAQ:NVGN): Australian/US biotechnology company</p><p>In this video, Dr. Graham Kelly, CEO of Novogen Group, briefly introduces Cantrixil and gives some details about the clinical program due to start in mid-2015.</p>
      <div class="videoWrapper"><iframe src="//www.youtube.com/embed/0zZoTLlZx2M?wmode=opaque&amp;enablejsapi=1" scrolling="no" allowfullscreen="" height="480" width="854" frameborder="0" id="yui_3_17_2_1_1419036551193_186">&lt;br/&gt;</iframe></div>
    </div>
  </article>
  </li>

<li>
  <div class="img-date"><img src="img/news-read-red.svg" alt="News Announcement"><p class="uk-text-muted">27 November 2014</p></div>
  <h1 uk-article-title>Latest Corporate Overview</h1>
</a>
<p>
  <a class="read-more uk-button uk-button-primary" data-uk-toggle="{target:'#pres-27november'}"> Read More</a>
</p>
<article class="uk-article uk-hidden" id="pres-27november">
  <div class="hidden-text-wrap">
    <p class="uk-article-meta">27 November 2014, Sydney, Australia: Novogen Limited (ASX:NRT; NASDAQ:NVGN): Australian/US biotechnology company</p><p > For the full download of the Corporate Overview
    <a href="pdf/corporateOverview27Nov2014.pdf" target="_blank">DOWNLOAD HERE</a>
    </p>
  </div>
</article>
</li>

<li>
  <div class="img-date"><img src="img/news-webinar-green.svg" alt="News Article"><p class="uk-text-muted">29 October 2014</p></div>
  <h1 uk-article-title>Recorded Investor Webinar</h1>
</a>
<p>
  <a class="read-more uk-button uk-button-primary" data-uk-toggle="{target:'#pres-29october'}"> Read More</a>
</p>
<article class="uk-article uk-hidden" id="pres-29october">
  <div class="hidden-text-wrap">
    <p class="uk-article-meta">29 October 2014</p><p></p>Recorded Webinar<p> A recorded version of the recent Investor Webinar given by Dr Kelly is available for viewing. The 30 minutes session includes a Q&amp;A segment and is available anytime HERE
    <a target="_blank" href="http://www.media-server.com/m/go/Novogen-20141029" id="yui_3_17_2_1_1419043460018_819">VIEW HERE</a>
    </p>
  </div>
</article>
</li>
<li>
  <div class="img-date"><img src="img/video-red.svg" alt="News Announcement"><p class="uk-text-muted">23 October 2014</p></div>
  <h1 uk-article-title>Video Interview with Dr Kelly at CMC TV.</h1>
</a>
<p>
  <a class="read-more uk-button uk-button-primary" data-uk-toggle="{target:'#pres-23october'}"> Read More</a>
</p>
<article class="uk-article uk-hidden" id="pres-23october">
  <div class="hidden-text-wrap">
    <p class="uk-article-meta">23 October 2014, Sydney, Australia: Novogen Limited (ASX:NRT;
      NASDAQ:NVGN): Australian/US biotechnology company</p><p>This is a short TV interview in which Dr Kelly answers questions on the company technology and the current Capital-Raising program.</p>
    <div class="videoWrapper"><iframe src="//www.youtube.com/embed/NRvuZr5c5Oc?wmode=opaque&amp;enablejsapi=1" scrolling="no" allowfullscreen="" height="480" width="854" frameborder="0" id="yui_3_17_2_1_1419036551193_186">&lt;br/&gt;</iframe></div>
  </div>
</article>
</li>
<li>
  <div class="img-date"><img src="img/video-green.svg" alt="News Announcement"><p class="uk-text-muted">23 October 2014</p></div>
  <h1 uk-article-title>Investment Opportunity Video</h1>
</a>
<p>
  <a class="read-more uk-button uk-button-primary" data-uk-toggle="{target:'#pres-20october'}"> Read More</a>
</p>
<article class="uk-article uk-hidden" id="pres-20october">
  <div class="hidden-text-wrap">
    <p class="uk-article-meta">20 October 2014, Sydney, Australia: Novogen Limited (ASX:NRT;
      NASDAQ:NVGN): Australian/US biotechnology company</p><p>This interview of Dr. Graham Kelly, Chairman and CEO of Novogen Group, gives a brief overview of the group's activity and focuses on its lead Oncology program, particularly Cantrixil.</p>
    <div class="videoWrapper"><iframe src="//www.youtube.com/embed/y9yTUO6k3kc?wmode=opaque&amp;enablejsapi=1" scrolling="no" allowfullscreen="" height="480" width="854" frameborder="0" id="yui_3_17_2_1_1419036551193_186">&lt;br/&gt;</iframe></div>
  </div>
</article>
</li>
<li>
  <div class="img-date"><img src="img/presentation-green.svg" alt="News Announcement"><p class="uk-text-muted"><p>September 2014</p></div>
  <h1 uk-article-title>Latest Novogen Corporate Presentation</h1>
</a>
<p>
  <a class="read-more uk-button uk-button-primary" data-uk-toggle="{target:'#pres-september'}"> Read More</a>
</p>
<article class="uk-article uk-hidden" id="pres-september">
  <div class="hidden-text-wrap">
    <p class="uk-article-meta">September 2014, Sydney, Australia: Novogen Limited (ASX:NRT; NASDAQ:NVGN): Australian/US biotechnology company</p><p> This update reflects some upgrades and revision on the previous edition.

    It is also accompanied by a Corporate Overview, which are notes that detail more fully the material contained on each slide of the presentation. You might find it useful to view both sections together.</p><p>
    <a href="pdf/corporatePresentationSept2014.pdf">DOWNLOAD the Coporate Overview HERE</a><br>
    <a href="pdf/corporateOverview2014.pdf">DOWNLOAD the Coporate presentation HERE</a>
    </p>
  </div>
</article>
</li>
<li>
  <div class="img-date"><img src="img/video-red.svg" alt="News Announcement"><p class="uk-text-muted">14 August 2014</p></div>
  <h1 uk-article-title>Novogen Open Briefing Reviews</h1>
</a>
<p>
  <a class="read-more uk-button uk-button-primary" data-uk-toggle="{target:'#pres-20october'}"> Read More</a>
</p>
<article class="uk-article uk-hidden" id="pres-20october">
  <div class="hidden-text-wrap">
    <p class="uk-article-meta">20 October 2014, Sydney, Australia: Novogen Limited (ASX:NRT;
      NASDAQ:NVGN): Australian/US biotechnology company</p><p class="uk-text-lead">CEO Graham Kelly recently hosted a meeting of open briefings that review the strategies for R&amp;D, the clinical trials and Novogen company growth.  This meeting was open both to shareholders and the public and the video segments below reflect those mini presentations.</p><p>This interview of Dr. Graham Kelly, Chairman and CEO of Novogen Group, gives a brief overview of the group's activity and focuses on its lead Oncology program, particularly Cantrixil.</p><p>Graham Kelly kicks off the proceedings with a a broad description of the company's progress to date and then goes on to lay out the future path the company will take. This is the subject of the first video presentation.</p>
    <p>There is a vast amount of  very exciting material contained within these various presentations. Please do keep coming back again after the first viewing.... you will certainly find them a great source of explanation now...  and as further reference in the future.</p>
    <div class="videoWrapper"><iframe src="//www.youtube.com/embed/RUkmM9blfEI?wmode=opaque&amp;enablejsapi=1" scrolling="no" allowfullscreen="" height="480" width="854" frameborder="0" id="yui_3_17_2_1_1419036551193_186">&lt;br/&gt;</iframe></div>
  </div>
  <p>This video was recorded on the 13th of August 2014 following Novogen's General Meeting. It is the collated version of the 3 presentations made during the meeting by:
  <p>
    Graham Kelly, PhD

    <em>Executive Chairman and CEO, Novogen</em>
  </p>
  <p>
    The titles of the 3 segments are..<br>
    <em>
      “The Novogen Opportunity… Cancer and Well Beyond”<br>

      “CanTx, Cantrixil and Abdominal Cancers”<br>

      “Summary, Growth and the Future”</em></p>
</article>
</li>
</ul>
</section>
<footer>
  <div class="uk-grid" style="margin-top: 0">
    <div class="footer-links uk-width-1-1 uk-width-small-1-2 uk-width-medium-1-4  uk-vertical-align uk-vertical-align-middle">
      <ul class="uk-list">
        <li><a href="index.html">Home</a></li>
        <li><a href="about.html">About</a></li>
        <li><a href="programs.html">Pipeline</a></li>
        <li><a href="investors.html">Investors</a></li>
        <li>
            <a href="pdf/termsConditions.pdf" target="_blank">Terms &amp; Conditions</a>
</li>
      </ul>
    </div>
    <ul class="shares-footer uk-list uk-list-space uk-hidden-small uk-width-medium-1-4  uk-vertical-align uk-vertical-align-middle">
      <li><a href="http://www.asx.com.au/asx/research/companyInfo.do?by=asxCode&asxCode=NRT" target="_blank"><img src="img/ASX.svg" alt="Australian Stock Exchange share price Novogen"></a></li>
      <li><a href="http://www.nasdaq.com/symbol/nvgn/sec-filings" target="_blank"><img src="img/nasdaq.svg" alt="Nasdaq share price Novogen"></a></li>
    </ul>
<!--
    <div id="terms-box" class="overflow uk-modal">
      <div class="overflow uk-modal-dialog uk-modal-dialog-large uk-height-viewport">
        <a class="uk-modal-close uk-close"></a>
        <iframe src="pdf/termsConditions.pdf" class="pdf"></iframe>
      </div>
    </div>
-->
    <div class="uk-width-1-1 uk-width-small-1-2 uk-width-medium-1-4  uk-vertical-align uk-vertical-align-middle">
      <!--
<form class="uk-form">

<fieldset data-uk-margin>
<legend>Sign up to stay informed</legend>
<input type="text" placeholder="you@email.com">
<button class="uk-button">SUBMIT</button>
</fieldset>

</form>
-->

      <form class="uk-form" name="catwebformform83042" method="post" onsubmit="return checkWholeForm83042(this)" enctype="multipart/form-data" action="/FormProcessv2.aspx?WebFormID=84800&OID={module_oid}&OTYPE={module_otype}&EID={module_eid}&CID={module_cid}">
        <fieldset data-uk-margin>
          <table class="webform" cellspacing="0" cellpadding="2" border="0"><tr><td><legend> Sign up to stay informed</legend><input type="text" placeholder="you@email.com" name="EmailAddress" id="EmailAddress" class="cat_textbox" style="width: 169px;" maxlength="255"/> </td></tr><tr><td><input class="cat_button uk-button" type="submit" value="Submit" id="catwebformbutton" /></td></tr></table>
        </fieldset>
        <script type="text/javascript" src="/CatalystScripts/ValidationFunctions.js"></script><script type="text/javascript">
        //<![CDATA[
        var submitcount83042 = 0;function checkWholeForm83042(theForm){var why = "";if (theForm.EmailAddress) why += checkEmail(theForm.EmailAddress.value); if(why != ""){alert(why);return false;}if(submitcount83042 == 0){submitcount83042++;theForm.submit();return false;}else{alert("Form submission is in progress.");return false;}}
        //]]>
        </script>
      </form>

    </div>
    <ul class="social-footer uk-list uk-list-space uk-hidden-small uk-width-medium-1-4 ">
      <li><a href="https://twitter.com/Novogen" target="_blank" ><img src="img/twitter.png" class="twitter-bottom uk-align-right" alt="twitter novogen"></a></li>
      <li><a href="https://www.linkedin.com/company/novogen" target="_blank"><img src="img/LinkedIn.svg" class="linkedin-bottom uk-align-right" alt="LinkedIn novogen"></a></li>
      <li><a href="https://www.youtube.com/channel/UCzNMflCMfqL-kTzanKU-gDQ" target="_blank"><img src="img/youtube.svg" class="utube-bottom uk-align-right" alt="Youtube novogen"></a></li>
    </ul>

  </div>
</footer>
<!--[if lt IE 9]>
<script>  if (!Modernizr.svg) {
  $('img[src$=".svg"]').each(function() {
      $(this).attr('src', $(this).attr('src').replace('.svg', '.png'));
  });
}
</script>
<![endif]-->
</body>
</html>
